Hailiang Ma

Shaoxing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Prevalence and risk factors of potentially inappropriate medications at discharge in older adults with heart failure: A retrospective observational pharmacovigilance study.

Prevalence and risk factors of potentially inappropriate medications at discharge in older adults with heart failure: A retrospective observational pharmacovigilance study.

Journal: Medicine
Published: April 28, 2026

Conservative management without routine bailout stent for non-flow-limiting dissection after DCB angioplasty: a prospective three-arm study.

Conservative management without routine bailout stent for non-flow-limiting dissection after DCB angioplasty: a prospective three-arm study.

Journal: Frontiers in cardiovascular medicine
Published: March 02, 2026

Ivabradine Versus Up-titrated Bisoprolol for Persistent Tachycardia After Primary PCI in Anterior STEMI: A Single-center, Open-label, Pragmatic RCT.

Ivabradine Versus Up-titrated Bisoprolol for Persistent Tachycardia After Primary PCI in Anterior STEMI: A Single-center, Open-label, Pragmatic RCT.

Journal: Cardiovascular drugs and therapy
Published: October 15, 2025

Impact of rhBNP and ivabradine on outcomes, cardiac markers, and microcirculation in ischemic heart failure.

Impact of rhBNP and ivabradine on outcomes, cardiac markers, and microcirculation in ischemic heart failure.

Journal: Heart & lung : the journal of critical care
Published: June 10, 2025

Pedunculoside inhibits cardiomyocyte inflammatory biomarkers via Nrf2/HO-1 pathway in high glucose-induced H9c2 cells and diabetic cardiomyopathy model rats.

Pedunculoside inhibits cardiomyocyte inflammatory biomarkers via Nrf2/HO-1 pathway in high glucose-induced H9c2 cells and diabetic cardiomyopathy model rats.

Journal: Human & experimental toxicology
Published: March 11, 2025

Lipoprotein(a) and the risk of type I cardiorenal syndrome in patients with coronary artery disease: A retrospective clinical study.

Lipoprotein(a) and the risk of type I cardiorenal syndrome in patients with coronary artery disease: A retrospective clinical study.

Journal: International journal of cardiology. Heart & vasculature
Published: September 11, 2024

Gypenoside A Protects Human Myocardial Cells from Ischemia/Reperfusion Injury via the circ_0010729/miR-370-3p/RUNX1 Axis.

Gypenoside A Protects Human Myocardial Cells from Ischemia/Reperfusion Injury via the circ_0010729/miR-370-3p/RUNX1 Axis.

Journal: Biochemistry. Biokhimiia
Published: June 16, 2024

Triptolide improves myocardial fibrosis in rats through inhibition of nuclear factor kappa B and NLR family pyrin domain containing 3 inflammasome pathway.

Triptolide improves myocardial fibrosis in rats through inhibition of nuclear factor kappa B and NLR family pyrin domain containing 3 inflammasome pathway.

Journal: The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology
Published: April 19, 2021
Showing 1-8 of 8

Last Updated: 09/26/2026